Cybin holds annual, special shareholder meeting; name change set for Oct. 1
CYBN•Shareholders approve board size and name change
Cybin held its annual and special shareholder meeting on Sept. 22, 2026.
Shareholders backed a plan to set the board size at eight directors.
Investors also endorsed changing the legal name to Helus Pharma, with the change set to take effect Oct. 1, 2026.
Zeifmans was appointed as auditor until the next annual shareholder meeting.
